Technology may offer tools to control growing opioid addiction

Cara Livernois | | Health Exec | Economics

With the opioid epidemic only getting worse, researchers and developers are working together fight addiction and misuse with medical technology. So has using medical technology helped at least slow the rise in opioid addiction?

Join VICE as it investigates the different technologies being used to stop opioid abuse in the U.S.

Read the full article by clicking the link below:

Can Better Medical Technology Stop the Opioid Epidemic?

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B
Why more doctors should pursue business and leadership training
Q&A: The role of employers in achieving healthcare price transparency
Medtronic’s diabetes spin-off gets a name, kicking off ‘new and exciting chapter’
Smaller revenues, less growth: In US, tariffs may create headaches for $34.5B cardiovascular device market
How private equity influences care for heart failure patients

Around the web

Cardiovascular Business
Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

Cardiovascular Business
AMA House of Delegates helps cardiology groups influence healthcare policies

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.

Cardiovascular Business
Smaller revenues, less growth: In US, tariffs may create headaches for $34.5B cardiovascular device market

“Without a more concrete and stable policy on these tariffs from the current American administration, it is likely that most manufacturers will be forced to continuously change their internal forecasts and production plans," one analyst said.